[1] |
徐如祥.丙戊酸钠的神经保护机制及临床应用[J].中华神经创伤外科电子杂志, 2017, 3(6): 325-329.
|
[2] |
McMorris T, Chu A, Vu L, et al. Hyperammonemia in patients receiving valproic acid in the hospital setting: a retrospective review[J]. Ment Health Clin, 2021, 11(4): 243-247.
|
[3] |
Gandolfo F, Parodi MN, Corsini GP, et al. Valproate-induced encephalopathy in a comorbid elderly woman[J]. Psychogeriatrics, 2017, 17(3): 208-209.
|
[4] |
Ando M, Amayasu H, Itai T, et al. Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid[J]. Biopsychosoc Med, 2017, 11: 19.
|
[5] |
Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid[J]. Clin Biochem, 2013, 46(15): 1323-1338.
|
[6] |
Duman B, Can KC, Ağtaş-Ertan E, et al. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions[J]. Gen Hosp Psychiatry, 2019, 59: 67-72.
|
[7] |
Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy[J]. Am J Health Syst Pharm, 2012, 69(1): 35-39.
|
[8] |
Tseng YL, Huang CR, Lin CH, et al. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy[J]. Medicine (Baltimore), 2014, 93(11): e66.
|
[9] |
Niclasen BH, Schelde-Olesen MT, Astvad M, et al. Hyperammonaemic encephalopathy caused by adult-onset ornithine transcarbamylase deficiency[J]. Brain Sci, 2022, 12(2): 231.
|
[10] |
Lewis C, Tesar GE, Dale R. Valproate-Induced hyperammonemic encephalopathy in general hospital patients with one or more psychiatric disorders[J]. Psychosomatics, 2017, 58(4): 415-420.
|
[11] |
Smith KM, Britton JW, Hocker SE, et al. Hyperammonemia in patients with status epilepticus treated with or without valproic acid[J]. Neurologist, 2021, 26(3): 80-82.
|
[12] |
丁茂华,董楠,王博,等.地西泮加重脑膜瘤术后并发丙戊酸钠脑病一例报道[J].中华神经医学杂志, 2017, 16(1): 88-89.
|
[13] |
Lewis C, Deshpande A, Tesar GE, et al. Valproate-induced hyperammonemic encephalopathy: a brief review[J]. Curr Med Res Opin, 2012, 28(6): 1039-1042.
|
[14] |
Kumar A, Suri A, Sharma BS. Severe valproate induced hyperammonemic encephalopathy successfully managed with peritoneal dialysis[J]. Indian J Crit Care Med, 2014, 18(7): 461-463.
|
[15] |
Chauhan VS, Dixit S, Goyal S, et al. Valproate induced hyperammonemic encephalopathy treated by haemodialysis[J]. Ind Psychiatry J, 2017, 26(1): 99-102.
|
[16] |
Chou HF, Yang RC, Chen CY, et al. Valproate-induced hyperammonemic encephalopathy[J]. Pediatr Neonatol, 2008, 49(5): 201-204.
|
[17] |
Chicharro AV, de Marinis AJ, Kanner AM. The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?[J]. Epilepsy Behav, 2007, 11(3): 361-366.
|
[18] |
Lee S, Cheong J, Kim C, et al. Valproic acid-induced hyperammonemic encephalopathy as a cause of neurologic deterioration after unruptured aneurysm surgery[J]. J Korean Neurosurg Soc, 2015, 58(2): 159-162.
|
[19] |
Lee HW, Osis G, Handlogten ME, et al. Effect of dietary protein restriction on renal ammonia metabolism[J]. Am J Physiol Renal Physiol, 2015, 308(12): F1463-F1473.
|
[20] |
Aires CC, van Cruchten A, Ijlst L, et al. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA[J]. J Hepatol, 2011, 55(2): 426-434.
|
[21] |
Zafar F, Billadeau BM, Ahmed AU. A case of valproate-induced hyperammonemic encephalopathy[J]. Cureus, 2020, 12(7): e9114.
|
[22] |
Nakadate K, Kamata S. Severe acute hepatic dysfunction induced by ammonium acetate treatment results in choroid plexus swelling and ventricle enlargement in the brain[J]. Int J Mol Sci, 2022, 23(4): 2010.
|
[23] |
Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain[J]. Metab Brain Dis, 2009, 24(1): 95-102.
|
[24] |
Chopra A, Kolla BP, Mansukhani MP, et al. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management[J]. Gen Hosp Psychiatry, 2012, 34(3): 290-298.
|
[25] |
Eubanks AL, Aguirre B, Bourgeois JA. Severe acute hyperammonemia after brief exposure to valproate[J]. Psychosomatics, 2008, 49(1): 82-83.
|
[26] |
Coates DR, Snart RS. Developmental aspects of steroid-induced ammonia release from isolated sections of rat intestine[J]. J Physiol, 1984, 354: 1-10.
|